Follow the Epigral Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Chemicals sector, Epigral Limited has published 45 reports. Market capitalisation: €34.9bn. The latest transaction was filed on 5 June 2023 (Purchase). Among the most active insiders: MAULIK JAYANTIBHAI PATEL. Every trade is free.
45
Insider Decl.
0
Thresholds
€2m
45 ops.
Buy Volume
·
0 ops.
Sell Volume
10Σ signal
Buys €2m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,049 of 26,111 companies
67.2
score / 100
Value
64
Quality
71
FCF yld1.0%
Earn yld7.7%
EV/EBITDA8.8x
ROE16%
Gross mgn40%
Net mgn13%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.